Dendritic cells and dinitrochlorobenzene (DNCB): a new treatment approach to AIDS
- 31 August 1991
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 29 (3) , 191-196
- https://doi.org/10.1016/0165-2478(91)90169-b
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Langerhans cells in HIV-1 infectionJournal of the American Academy of Dermatology, 1990
- Dendritic cells in contact sensitivityResearch in Immunology, 1989
- Structural and functional relationships between epidermal Langerhans cells and dendritic cellsResearch in Immunology, 1989
- Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected PersonsNew England Journal of Medicine, 1989
- Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicityArchiv für die gesamte Virusforschung, 1989
- Contact immunotherapy of resistant wartsJournal of the American Academy of Dermatology, 1988
- Role of epidermal Langerhans cells in viral infectionsArchiv für die gesamte Virusforschung, 1988
- Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complexJournal of the American Academy of Dermatology, 1987
- Stimulation of T-cellular immunity by cutaneous application of dinitrochlorobenzeneJournal of the American Academy of Dermatology, 1986
- Dinitrochlorobenzene immunotherapy for verrucae resistant to standard treatment modalitiesJournal of the American Academy of Dermatology, 1982